Sign in
Back
Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients
Journal article   Peer reviewed

Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients

Daniel Bichet, Pol Boudes, Sharaf El Din, Fatih Ezgu, Claudio Feliciani, Anna Zampetti, Charles Marques Lourenco, Kathy Nicholls, Jeff Castelli, Chemise Overton, …
Molecular genetics and metabolism, Vol.105(2), pp.S21-S21
02/2012
DOI: https://doi.org/10.1016/j.ymgme.2011.11.029

Metrics

1 Record Views

Details